Page last updated: 2024-08-17

medroxyprogesterone acetate and Vaginal Discharge

medroxyprogesterone acetate has been researched along with Vaginal Discharge in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McFadyen, L; Preston-Whyte, E; Smit, J; Zuma, K1
Beksinska, ME; Rees, HV1
Singh, V; Strickland, J; Talib, N1
Jackson, DJ; Kreiss, J; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA1

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Vaginal Discharge

ArticleYear
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Social science & medicine (1982), 2002, Volume: 55, Issue:9

    Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Cross-Sectional Studies; Family Characteristics; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Interviews as Topic; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Qualitative Research; Rural Population; Sexual Partners; South Africa; Vaginal Discharge

2002
Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    African journal of reproductive health, 2001, Volume: 5, Issue:3

    Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; South Africa; Vaginal Discharge

2001
Decidual cast in a girl receiving depot medroxyprogesterone acetate--a case report.
    Journal of pediatric and adolescent gynecology, 2007, Volume: 20, Issue:3

    Topics: Child; Contraceptive Agents, Female; Decidua; Delayed-Action Preparations; Female; Humans; Intellectual Disability; Medroxyprogesterone Acetate; Puberty, Precocious; Vaginal Discharge

2007
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:4

    Topics: Behavior; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Contraceptive Devices; Demography; Female; HIV Seropositivity; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; Multivariate Analysis; Prospective Studies; Risk Factors; Sex Work; Sexually Transmitted Diseases; Ulcer; Vaginal Discharge; Vulvitis

1998